Clinical Trial Update: A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT) [Phase 2]

View source ↗

Summary

This is a Phase II prospective, single-arm trial evaluating a PD-L1 monoclonal antibody combined with chemoradiotherapy as a bridge to liver transplantation for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perihilar Cholangiocarcinoma

Drugs mentioned

• PD-L1 monoclonal antibody (unspecified)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Locally Advanced Perihilar Cholangiocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING